Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3020% below fair value
$9.17+0.06 (+0.66%)
Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –
Viemed Healthcare gross margin
Gross margin is gross profit as a percentage of revenue.
Viemed Healthcare's gross margin for the twelve months ending Sep 30, 2026 was 57.4%. For fiscal 2025 it was 57.5%, against 59.4% the year before. The highest annual figure on record is 74.1% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.5% | −1.9 |
| FY2024 | Dec 31, 2024 | 59.4% | −2.2 |
| FY2023 | Dec 31, 2023 | 61.6% | +0.6 |
| FY2022 | Dec 31, 2022 | 61.0% | −1.7 |
| FY2021 | Dec 31, 2021 | 62.7% | +1.7 |
| FY2020 | Dec 31, 2020 | 61.0% | −8.8 |
| FY2019 | Dec 31, 2019 | 69.8% | −4.3 |
| FY2018 | Dec 31, 2018 | 74.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 57.3% | −0.2 |
| Q2 FY2026 | Jun 30, 2026 | 57.7% | −0.6 |
| Q1 FY2026 | Mar 31, 2026 | 56.8% | +0.5 |
| Q4 FY2025 | Dec 31, 2025 | 57.9% | −1.6 |
| Q3 FY2025 | Sep 30, 2025 | 57.5% | −1.8 |
| Q2 FY2025 | Jun 30, 2025 | 58.3% | −1.6 |
| Q1 FY2025 | Mar 31, 2025 | 56.3% | −2.6 |
| Q4 FY2024 | Dec 31, 2024 | 59.5% | −3.7 |
| Q3 FY2024 | Sep 30, 2024 | 59.3% | −2.6 |
| Q2 FY2024 | Jun 30, 2024 | 59.8% | −0.4 |
| Q1 FY2024 | Mar 31, 2024 | 58.9% | −1.8 |
| Q4 FY2023 | Dec 31, 2023 | 63.3% | +2.2 |
| Q3 FY2023 | Sep 30, 2023 | 61.9% | +1.3 |
| Q2 FY2023 | Jun 30, 2023 | 60.3% | −0.9 |
| Q1 FY2023 | Mar 31, 2023 | 60.7% | −0.5 |
| Q4 FY2022 | Dec 31, 2022 | 61.0% | −0.5 |
| Q3 FY2022 | Sep 30, 2022 | 60.5% | −2.2 |
| Q2 FY2022 | Jun 30, 2022 | 61.2% | −3.1 |
| Q1 FY2022 | Mar 31, 2022 | 61.2% | −1.2 |
| Q4 FY2021 | Dec 31, 2021 | 61.5% | +0.1 |
| Q3 FY2021 | Sep 30, 2021 | 62.8% | +4.6 |
| Q2 FY2021 | Jun 30, 2021 | 64.3% | +3.8 |
| Q1 FY2021 | Mar 31, 2021 | 62.4% | −2.9 |
| Q4 FY2020 | Dec 31, 2020 | 61.5% | −4.9 |
| Q3 FY2020 | Sep 30, 2020 | 58.2% | −10.8 |
| Q2 FY2020 | Jun 30, 2020 | 60.5% | −11.5 |
| Q1 FY2020 | Mar 31, 2020 | 65.3% | −6.8 |
| Q4 FY2019 | Dec 31, 2019 | 66.4% | −7.2 |
| Q3 FY2019 | Sep 30, 2019 | 69.0% | −6.8 |
| Q2 FY2019 | Jun 30, 2019 | 72.0% | −0.5 |
| Q1 FY2019 | Mar 31, 2019 | 72.2% | −2.3 |
| Q4 FY2018 | Dec 31, 2018 | 73.6% | – |
| Q3 FY2018 | Sep 30, 2018 | 75.8% | – |
| Q2 FY2018 | Jun 30, 2018 | 72.5% | – |
| Q1 FY2018 | Mar 31, 2018 | 74.5% | – |
See a number that looks wrong?